FDA gives full approval to Novavax COVID shot for high-risk groups

The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax’s COVID-19 vaccine, but only for certain people.

Leave A Comment

Your email address will not be published. Required fields are marked *